The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | R | Respiratory system | |
2 | R06 | Antihistamines for systemic use | |
3 | R06A | Antihistamines for systemic use | |
4 | R06AB | Substituted alkylamines |
Code | Title | |
---|---|---|
R06AB01 | Brompheniramine | |
R06AB02 | Dexchlorpheniramine | |
R06AB03 | Dimetindene | |
R06AB04 | Chlorphenamine | |
R06AB05 | Pheniramine | |
R06AB06 | Dexbrompheniramine | |
R06AB07 | Talastine | |
R06AB51 | Brompheniramine, combinations | |
R06AB52 | Dexchlorpheniramine, combinations | |
R06AB54 | Chlorphenamine, combinations | |
R06AB56 | Dexbrompheniramine, combinations |
Active Ingredient | Description | |
---|---|---|
Brompheniramine |
|
|
Chlorphenamine |
Chlorphenamine is a potent antihistamine (H1-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H1-receptor sites on tissues. Chlorphenamine also has anticholinergic activity. |
|
Dexchlorpheniramine |
Dexchlorpheniramine, the d-isomer of the racemic compound chlorpheniramine, is two times more active than chlorpheniramine. Dexchlorpheniramine does not prevent the release of histamine, but rather, competes with free histamine for binding at the H1-receptor sites, and competitively antagonizes the effects of histamine on H1-receptors in the GI tract, uterus, large blood vessels, and bronchial muscle. Blockade of H1-receptors also suppresses the formation of oedema, flare, and pruritus that result from histaminic activity. Since dexchlorpheniramine binds to central and peripheral H1-receptors, sedative effects are likely to occur. Dexchlorpheniramine has high antihistaminic activity, moderate anticholinergic effects and minimal sedative effects. |
|
Dimetindene |
Dimetindene is an antihistaminic of the alkylamine group. Its action is the result of the capture of histamine Η1 subunits. It has mild anticholinergic and sedative action. |
|
Pheniramine |
|
Title | Information Source | Document Type | |
---|---|---|---|
FENISTIL Oral drops, solution | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
HAYLEVE Tablet | MPI, EU: SmPC | ||
PIRITON Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
RHINETON Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic |